药理动力学分析仪 (PhaKinPro):模型开发,验证和实施作为一种用于分类具有不良药理动力学特征的化合物的网络工具
Marielle Rath1, James Wellnitz1, Holli-Joi Martin1
1Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
Journal of medicinal chemistry
|April 3, 2024
概括
计算模型预测药物特性,以改善药物发现. 开发的定量结构-活性关系 (QSAR) 模型准确评估候选药物,有助于选择有前途的化合物.
科学领域:
- 计算化学和化学信息学
- 药物的发现和开发.
- 药理动力学和药物代谢的药理动力学
背景情况:
- 准确预测药理动力学特性对于有效的药物候选者优先级是必不可少的.
- 高通量查产生了大量的药物命中,需要快速评估.
- 定量结构-活性关系 (QSAR) 模型提供了一个计算方法来预测药物行为.
研究的目的:
- 开发和验证可靠的二元QSAR模型来预测药理动力学特性.
- 创建一个全面的药物化合物药理动力学数据数据库.
- 让这些预测模型可用于更广泛的药物发现.
主要方法:
- 收集,策划和整合了一个数据库,包含超过1万种独特的化合物,具有12个药理动力学终点.
- 开发并验证了使用策划数据集的二元定量结构-活动关系 (QSAR) 模型.
- 应用训练的QSAR模型来预测NCATSInxight药物和DrugBank数据库中的化合物的药动力学特性.
主要成果:
- 所有开发的QSAR模型都显示正确分类率高于0.60.
- 模型的积极预测值超过了0.50,表明可靠的预测.
- 对广泛的药物化合物库的药理动力学特性进行成功预测.
结论:
- 开发的QSAR模型提供了一个有价值的工具,用于降低药物候选者的优先级,这些药物具有不利的药物动力学特征.
- 综合模型和网络门户 (PhaKinPro) 提高了药物发现研究人员的可访问性.
- 这些计算工具可以显著加速药物开发管道的早期阶段.
相关概念视频
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Pharmacokinetic Models: Overview
672
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
672
Pharmacokinetics: Overview
6.3K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.3K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
170
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
170
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
123
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
123


